Magnolia NeuroSciences Company

Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.
Technology: Neuropharmacology
Industry: NeuroTech
Headquarters: United States
Founded Date: 2018
Employees Number: 1-10
Funding Status: N/A

Visit Website
info@magnolianeurosciences.com
Register and Claim Ownership